Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.42 HKD | -3.45% | +21.74% | -32.26% |
04-12 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
04-08 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.26% | 72.22M | |
+8.96% | 105B | |
-1.43% | 104B | |
+5.24% | 22.94B | |
-12.15% | 22.34B | |
-6.77% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- 2197 Stock
- News Clover Biopharmaceuticals, Ltd.
- Clover Bio's COVID Vaccine Candidate to Begin Phase 2 Clinical Trial as Booster Dose